VCRE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vicore Pharma Holding AB

Watchlist Manager

Watchlist

Price: 9.44 USD 3.06% Market Closed

Market Cap: $2.7B

	Vicore Pharma Holding AB NASDAQ:VCRE	SE
A	Aston Martin Lagonda Global Holdings PLC OTC:AMGDF	UK
B	Brimstone Investment Corporation Ltd JSE:BRN	ZA
	CATRION Catering Holding Company SJSC SAU:6004	SA
	SPIC Hydropower Co Ltd SSE:600292	CN
S	Stef SA F:STP	FR
A	Aminex PLC OTC:AEXFF	UK
	Prestige Estates Projects Ltd NSE:PRESTIGE	IN
	Colefax Group PLC LSE:CFX	UK
	Ambea publ AB F:6MA	SE
	Leonteq AG F:EFL	CH
V	Via Transportation Inc F:C0I	US
G	Gen Digital Inc XHAM:SYM	US

Profitability Summary

Vicore Pharma Holding AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-13 110%

Negative 3Y Average Operating Margin

-5 415%

Negative Net Margin

-12 570%

Negative 3Y Average Net Margin

-5 426%

Negative Free Cash Flow Margin

-11 435%

Negative 3Y Average Free Cash Flow Margin

-4 632%

Negative ROE

-57%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3 230%

Declining ROIC

-607% > -7 287%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.